<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vladimir Alexandrovich Naumov | AI Biotech Architect</title>
    <style>
        /* Distill / Tufte Style CSS */
        :root {
            --accent: #D04040; /* Distill Red */
            --bg: #FDFDFD;
            --text: #333;
            --secondary: #666;
            --timeline-line: #E0E0E0;
        }

        body {
            font-family: 'Georgia', 'Times New Roman', serif; /* Serif for main text */
            background-color: var(--bg);
            color: var(--text);
            line-height: 1.6;
            margin: 0;
            padding: 0;
            font-size: 18px;
        }

        /* Typography */
        h1, h2, h3, h4 {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, Helvetica, Arial, sans-serif; /* Sans for headers */
            font-weight: 600;
            color: #111;
            margin-top: 0;
        }

        h1 { font-size: 2.5rem; margin-bottom: 0.5rem; }
        h2 { font-size: 1.5rem; border-bottom: 1px solid #eee; padding-bottom: 0.5rem; margin-top: 3rem; }
        h3 { font-size: 1.2rem; margin-bottom: 0.5rem; color: #444; }
        
        .subtitle {
            font-family: -apple-system, BlinkMacSystemFont, sans-serif;
            font-size: 1.1rem;
            color: var(--secondary);
            font-weight: 300;
            margin-bottom: 2rem;
        }

        /* Layout */
        .container {
            max-width: 1200px; /* Increased max-width for better balance with 33% sidebar */
            margin: 0 auto;
            padding: 4rem 2rem;
            display: grid;
            grid-template-columns: 33% 1fr; /* Updated: Left part is 33% of width */
            gap: 4rem;
        }

        /* Sidebar / CTA */
        .sidebar {
            font-family: -apple-system, BlinkMacSystemFont, sans-serif;
            font-size: 0.95rem; /* Slightly larger for readability on wider column */
            position: sticky;
            top: 0;
            min-height: calc(100vh - 8rem); /* Fill viewport height while respecting container padding */
            height: fit-content;
        }

        .profile-img {
            width: 100%;
            max-width: 250px; /* Cap size so it doesn't get huge */
            border-radius: 8px;
            margin-bottom: 1.5rem;
            box-shadow: 0 4px 6px rgba(0,0,0,0.1);
            display: block;
        }

        .lang-switch {
            margin-bottom: 1.5rem;
            display: flex;
            gap: 10px;
        }
        .lang-btn {
            background: none;
            border: 1px solid #ccc;
            border-radius: 4px;
            padding: 4px 8px;
            font-size: 0.8rem;
            cursor: pointer;
            font-family: -apple-system, BlinkMacSystemFont, sans-serif;
            color: #666;
        }
        .lang-btn.active {
            background: var(--accent);
            color: white;
            border-color: var(--accent);
        }

        .cta-box {
            background: #f4f4f4;
            padding: 1.5rem;
            border-radius: 8px;
            border-left: 4px solid var(--accent);
            margin-bottom: 2rem;
        }

        .cta-box h4 { margin-bottom: 0.75rem; color: var(--accent); font-size: 1rem; }
        .cta-box p { margin: 0 0 0.8rem 0; font-size: 0.9rem; color: #444; line-height: 1.5; }
        .cta-box ul { padding-left: 1.2rem; margin: 0; font-size: 0.9rem; color: #444; }
        .cta-box li { margin-bottom: 0.5rem; }
        
        .contact-links a {
            display: flex;
            align-items: center;
            margin-bottom: 0.8rem;
            color: var(--text);
            text-decoration: none;
            font-weight: 500;
            transition: color 0.2s;
        }
        .contact-links a:hover { color: var(--accent); }
        .contact-icon { margin-right: 10px; width: 18px; text-align: center; }

        .tag {
            display: inline-block;
            background: #eee;
            padding: 3px 10px;
            border-radius: 4px;
            font-size: 0.8rem;
            margin-right: 5px;
            margin-bottom: 5px;
            color: #555;
        }

        /* Timeline Styles */
        .timeline-phase {
            position: relative;
            padding-left: 2rem;
            margin-bottom: 4rem;
            border-left: 2px solid var(--timeline-line);
        }

        .phase-marker {
            position: absolute;
            left: -12px;
            top: 0;
            width: 22px;
            height: 22px;
            background: var(--bg);
            border: 2px solid var(--accent);
            border-radius: 50%;
        }

        .phase-title {
            font-family: -apple-system, BlinkMacSystemFont, sans-serif;
            text-transform: uppercase;
            letter-spacing: 1px;
            font-size: 0.9rem;
            color: var(--accent);
            margin-bottom: 1rem;
            font-weight: bold;
        }

        /* Article Card */
        .article {
            margin-bottom: 2.5rem;
        }

        .article-meta {
            font-family: -apple-system, BlinkMacSystemFont, sans-serif;
            font-size: 0.85rem;
            color: var(--secondary);
            margin-bottom: 0.2rem;
        }

        .article-title {
            font-size: 1.15rem;
            font-weight: 600;
            margin-bottom: 0.5rem;
            line-height: 1.4;
            color: #222;
        }

        .abstract-box {
            font-size: 0.95rem;
            background: #fcfcfc;
            border-left: 3px solid #ddd;
            padding: 1rem;
            margin-top: 0.5rem;
            color: #444;
        }

        /* Language Utility Classes */
        [lang="ru"], [lang="zh"] { display: none; }

        /* Responsive */
        @media (max-width: 768px) {
            .container { grid-template-columns: 1fr; padding: 2rem 1.5rem; }
            .sidebar { position: relative; top: 0; margin-bottom: 3rem; min-height: auto; }
            .profile-img { max-width: 150px; margin-bottom: 1.5rem; }
        }
    </style>
</head>
<body>

<div class="container">

    <aside class="sidebar">
        <!-- Language Switcher -->
        <div class="lang-switch">
            <button class="lang-btn active" onclick="setLang('en')">EN</button>
            <button class="lang-btn" onclick="setLang('ru')">RU</button>
            <button class="lang-btn" onclick="setLang('zh')">中文</button>
        </div>

        <!-- Profile Image -->
        <img src="img/Gemini_Generated_Image_yi0p6zyi0p6zyi0p.jpg" alt="Vladimir Alexandrovich Naumov" class="profile-img">

        <div class="cta-box">
            <h4>
                <span lang="en">Advisory for Series A Startups</span>
                <span lang="ru">Консалтинг для стартапов (Series A)</span>
                <span lang="zh">A轮初创企业咨询服务</span>
            </h4>
            
            <p><strong>
                <span lang="en">End-to-End AI Pipeline Architecture</span>
                <span lang="ru">Сквозная архитектура AI-пайплайнов</span>
                <span lang="zh">端到端人工智能管道架构</span>
            </strong></p>
            
            <p>
                <span lang="en">I bridge the gap between wet-lab biology and production-grade AI, helping startups validate their tech stack for Series B scaling.</span>
                <span lang="ru">Я соединяю мокрую (wet-lab) биологию и промышленный ИИ, помогая стартапам валидировать технологический стек для масштабирования серии B.</span>
                <span lang="zh">我弥合了湿实验生物学与生产级人工智能之间的差距，帮助初创企业验证其技术栈以实现B轮扩展。</span>
            </p>
            
            <ul>
                <li>
                    <span lang="en"><strong>Scalable Infrastructure:</strong> Design secure, cloud-agnostic MLOps environments (AWS/GCP) for high-throughput multi-omics data.</span>
                    <span lang="ru"><strong>Масштабируемая инфраструктура:</strong> Проектирование защищенных MLOps сред (AWS/GCP) для высокопроизводительных мультиомных данных.</span>
                    <span lang="zh"><strong>可扩展基础设施：</strong> 为高通量多组学数据设计安全、云无关的 MLOps 环境 (AWS/GCP)。</span>
                </li>
                <li>
                    <span lang="en"><strong>Generative Engines:</strong> Deploy custom LLMs & Transformers for target ID, de novo molecule design, and automated report generation.</span>
                    <span lang="ru"><strong>Генеративные движки:</strong> Развертывание LLM и Трансформеров для поиска мишеней, de novo дизайна молекул и генерации отчетов.</span>
                    <span lang="zh"><strong>生成式引擎：</strong> 部署定制的大型语言模型 (LLM) 和 Transformer，用于靶点识别、从头分子设计和自动化报告生成。</span>
                </li>
                <li>
                    <span lang="en"><strong>Strategic Roadmaps:</strong> "Buy vs. Build" technical strategy, AI team assembly, and regulatory-ready data governance.</span>
                    <span lang="ru"><strong>Стратегия:</strong> Технический анализ "Buy vs. Build", формирование AI-команд и управление данными (Data Governance).</span>
                    <span lang="zh"><strong>战略路线图：</strong> “购买与构建”技术战略、AI 团队组建以及符合监管要求的数据治理。</span>
                </li>
            </ul>
        </div>

        <div style="margin-bottom: 2rem;">
            <h4>
                <span lang="en">Connect</span>
                <span lang="ru">Связаться</span>
                <span lang="zh">联系方式</span>
            </h4>
            <div class="contact-links">
                <a href="https://t.me/vovalive" target="_blank">
                    <span class="contact-icon">➤</span> Telegram (Direct)
                </a>
                <a href="mailto:your.email@example.com">
                    <span class="contact-icon">✉</span> Email Me
                </a>
                <a href="https://linkedin.com/in/yourprofile" target="_blank">
                    <span class="contact-icon">in</span> LinkedIn
                </a>
            </div>
        </div>

        <div>
            <h4>
                <span lang="en">Core Expertise</span>
                <span lang="ru">Ключевые компетенции</span>
                <span lang="zh">核心专长</span>
            </h4>
            
            <div lang="en">
                <span class="tag">Generative AI</span>
                <span class="tag">Transformers</span>
                <span class="tag">Drug Discovery</span>
                <span class="tag">Multi-Omics</span>
                <span class="tag">MLOps</span>
                <span class="tag">Bioinformatics</span>
            </div>
            
            <div lang="ru">
                <span class="tag">Генеративный ИИ</span>
                <span class="tag">Трансформеры</span>
                <span class="tag">Drug Discovery</span>
                <span class="tag">Мультиомика</span>
                <span class="tag">MLOps</span>
                <span class="tag">Биоинформатика</span>
            </div>

            <div lang="zh">
                <span class="tag">生成式 AI</span>
                <span class="tag">Transformer</span>
                <span class="tag">药物发现</span>
                <span class="tag">多组学</span>
                <span class="tag">MLOps</span>
                <span class="tag">生物信息学</span>
            </div>
        </div>
    </aside>

    <main>
        <header>
            <h1>
                <span lang="en">Vladimir Alexandrovich Naumov</span>
                <span lang="ru">Владимир Александрович Наумов</span>
                <span lang="zh">弗拉基米尔·亚历山德罗维奇·瑙莫夫</span>
            </h1>
            <div class="subtitle">
                <span lang="en">From Genomic Association to Generative Artificial Intelligence</span>
                <span lang="ru">От геномных ассоциаций к генеративному искусственному интеллекту</span>
                <span lang="zh">从基因组关联到生成式人工智能</span>
            </div>
            <p>
                <span lang="en">
                    My scientific path has evolved from fundamental wet-lab genetics to pioneering 
                    <strong>Generative Biology</strong>. I build virtual research teams, multi-modal transformer models, 
                    and autonomous AI agents to accelerate therapeutic discovery.
                </span>
                <span lang="ru">
                    Мой научный путь прошел эволюцию от фундаментальной генетики к передовой 
                    <strong>Генеративной Биологии</strong>. Я создаю виртуальные исследовательские команды, мультимодальные трансформеры 
                    и автономных AI-агентов для ускорения поиска новых лекарств.
                </span>
                <span lang="zh">
                    我的科学道路已从基础湿实验遗传学演变为开创性的<strong>生成生物学</strong>。
                    我构建虚拟研究团队、多模态 Transformer 模型和自主 AI 代理，以加速药物发现。
                </span>
            </p>
        </header>

        <div class="timeline-phase">
            <div class="phase-marker"></div>
            <div class="phase-title">
                <span lang="en">Phase III: The AI & Generative Biology Revolution (2021–Present)</span>
                <span lang="ru">Этап III: Революция AI и Генеративной Биологии (2021–Наст. время)</span>
                <span lang="zh">第三阶段：人工智能与生成生物学革命 (2021–至今)</span>
            </div>
            <p style="font-size: 0.95rem; color: #555; margin-bottom: 2rem;">
                <em lang="en">Transition to high-tech industry. Focus on Transformers, Multi-Agent Systems, and AI-Driven Drug Discovery</em>
                <em lang="ru">Переход в хайтек-индустрию. Фокус на Трансформерах, Мультиагентных системах и AI-дизайне лекарств.</em>
                <em lang="zh">转型高科技产业。专注于 Transformer、多智能体系统和 AI 驱动的药物发现。</em>
            </p>

            <div class="article">
                <div class="article-meta">2025 • bioRxiv</div>
                <div class="article-title">Dora AI Scientist: Multi-agent Virtual Research Team for Scientific Exploration Discovery and Automated Report Generation</div>
                <div class="abstract-box">
                    <span lang="en"><strong>Key Abstract:</strong> We introduce a versatile multi-agent scientific exploration and draft outline research assistant (DORA). Under user guidance, it employs hierarchical teams of AI agents based on plug-and-play generalist and domain-specific LLMs. It automates hypothesis generation, data analysis, and report writing.</span>
                    <span lang="ru"><strong>Абстракт:</strong> Мы представляем DORA — мультиагентного ассистента. Иерархические команды AI-агентов автоматизируют генерацию гипотез, анализ данных и написание отчетов, выступая как «виртуальная исследовательская группа».</span>
                    <span lang="zh"><strong>摘要:</strong> 我们推出了多智能体科学探索与起草助手 DORA。在用户指导下，AI 代理团队可自动生成假设、分析数据并撰写报告，从而创建一个“虚拟研究团队”。</span>
                </div>
            </div>

            <div class="article">
                <div class="article-meta">2024 • bioRxiv</div>
                <div class="article-title">Precious3GPT: Multimodal Multi-Species Multi-Omics Multi-Tissue Transformer for Aging Research</div>
                <div class="abstract-box">
                    <span lang="en"><strong>Key Abstract:</strong> A landmark multimodal transformer model trained on vast biological datasets. It treats biological data (omics, tissue types, species) as a language, allowing for the generation of synthetic data and the identification of novel therapeutic targets for aging.</span>
                    <span lang="ru"><strong>Абстракт:</strong> Мультимодальная модель трансформера, обученная на огромных био-датасетах. Она трактует биологические данные как язык, позволяя генерировать синтетические данные и искать новые мишени старения.</span>
                    <span lang="zh"><strong>摘要:</strong> 基于海量生物数据训练的里程碑式多模态 Transformer 模型。它将生物数据视为一种语言，允许生成合成数据并识别衰老的新治疗靶点。</span>
                </div>
            </div>

            <div class="article">
                <div class="article-meta">2023 • Chemical Science</div>
                <div class="article-title">AlphaFold accelerates artificial intelligence powered drug discovery: Efficient discovery of a novel CDK20 inhibitor</div>
                <div class="abstract-box">
                    <span lang="en"><strong>Key Abstract:</strong> Demonstrating the first application of AlphaFold in a hit identification process. We utilized AlphaFold predicted structures to discover a novel small molecule inhibitor for CDK20 in under 30 days.</span>
                    <span lang="ru"><strong>Абстракт:</strong> Первое применение AlphaFold для поиска хитов. Мы использовали предсказанные структуры для открытия нового ингибитора CDK20 менее чем за 30 дней.</span>
                    <span lang="zh"><strong>摘要:</strong> 展示了 AlphaFold 在苗头化合物识别过程中的首次应用。我们在 30 天内发现了一种新型 CDK20 小分子抑制剂。</span>
                </div>
            </div>

            <div class="article">
                <div class="article-meta">2024 • npj Aging</div>
                <div class="article-title">Precious2GPT: The combination of multiomics pretrained transformer and conditional diffusion</div>
            </div>
            <div class="article">
                <div class="article-meta">2023 • Aging (Albany NY)</div>
                <div class="article-title">Precious1GPT: Multimodal transformer-based transfer learning for aging clock development</div>
            </div>
             <div class="article">
                <div class="article-meta">2021 • PLoS Computational Biology</div>
                <div class="article-title">COVIDomic: A multi-modal cloud-based platform for identification of risk factors</div>
            </div>
        </div>

        <div class="timeline-phase">
            <div class="phase-marker" style="border-color: #666;"></div>
            <div class="phase-title">
                <span lang="en">Phase II: Systems Biology, Reproductive Health & Tool Development (2015–2020)</span>
                <span lang="ru">Этап II: Системная биология и разработка инструментов (2015–2020)</span>
                <span lang="zh">第二阶段：系统生物学与工具开发 (2015–2020)</span>
            </div>
            <p style="font-size: 0.95rem; color: #555; margin-bottom: 2rem;">
                <em lang="en">Shift from single genes to transcriptomics and epigenetics. Development of bioinformatics algorithms and clinical decision support systems.</em>
                <em lang="ru">Переход от отдельных генов к транскриптомике и эпигенетике. Разработка биоинформатических алгоритмов и систем поддержки принятия клинических решений.</em>
                <em lang="zh">从单基因转向转录组学和表观遗传学。开发生物信息学算法和临床决策支持系统。</em>
            </p>

            <div class="article">
                <div class="article-meta">2017 • bioRxiv</div>
                <div class="article-title">VolcanoR-web service to produce volcano plots and do basic enrichment analysis</div>
                <div class="abstract-box">
                    <span lang="en"><strong>Key Abstract:</strong> Development of an accessible web service (R Shiny) that democratized bioinformatics visualization. It allowed users to instantly generate publication-quality volcano plots.</span>
                    <span lang="ru"><strong>Абстракт:</strong> Веб-сервис (R Shiny), демократизировавший биоинформатическую визуализацию. Позволяет мгновенно строить volcano plots публикационного качества.</span>
                    <span lang="zh"><strong>摘要:</strong> 开发了一个易于访问的 Web 服务 (R Shiny)，使得生物信息学可视化大众化。它允许用户立即生成出版级质量的火山图。</span>
                </div>
            </div>

            <div class="article">
                <div class="article-meta">2020 • Epigenomics</div>
                <div class="article-title">Rat liver epigenome programing by perinatal exposure to flame retardants</div>
            </div>
            <div class="article">
                <div class="article-meta">2019 • European Journal of Human Genetics</div>
                <div class="article-title">The first private all-Russian genome initiative - #500genomes from Zenome</div>
            </div>
            <div class="article">
                <div class="article-meta">2017 • Gynecological Endocrinology</div>
                <div class="article-title">Transcription profile analysis of the endometrium: Molecular markers of the ‘window of implantation’</div>
            </div>
            <div class="article">
                <div class="article-meta">2016 • Cell Cycle</div>
                <div class="article-title">An integrative analysis of reprogramming in human isogenic system identified a clone selection criterion</div>
            </div>
        </div>

        <div class="timeline-phase">
            <div class="phase-marker" style="border-color: #999;"></div>
            <div class="phase-title">
                <span lang="en">Phase I: The Genomic Association Era (2012–2015)</span>
                <span lang="ru">Этап I: Эра геномных ассоциаций (2012–2015)</span>
                <span lang="zh">第一阶段：基因组关联时代 (2012–2015)</span>
            </div>
            <p style="font-size: 0.95rem; color: #555; margin-bottom: 2rem;">
                <em lang="en">Foundational research in molecular genetics. Investigating SNPs associated with oncology (bone tumors) and athletic performance.</em>
                <em lang="ru">Фундаментальные исследования в молекулярной генетике. Поиск SNP, связанных с онкологией и спортивной генетикой.</em>
                <em lang="zh">分子遗传学的基础研究。调查与肿瘤学（骨肿瘤）和运动表现相关的 SNP。</em>
            </p>

            <div class="article">
                <div class="article-meta">2015 • Biology of Sport</div>
                <div class="article-title">Genome-wide association study identifies three novel genetic markers associated with elite endurance performance</div>
            </div>
            <div class="article">
                <div class="article-meta">2014 • Experimental Physiology</div>
                <div class="article-title">AGTR2 gene polymorphism is associated with muscle fibre composition and athletic status</div>
            </div>
            <div class="article">
                <div class="article-meta">2012 • Bulletin of Exp. Bio. & Med.</div>
                <div class="article-title">Association of FGFR3 and MDM2 gene nucleotide polymorphisms with bone tumors</div>
            </div>
        </div>

    </main>
</div>

<script>
    function setLang(lang) {
        // Remove active class from all buttons
        document.querySelectorAll('.lang-btn').forEach(btn => btn.classList.remove('active'));
        
        // Add active class to clicked button
        const btnText = lang === 'en' ? 'EN' : lang === 'ru' ? 'RU' : '中文';
        const buttons = Array.from(document.querySelectorAll('.lang-btn'));
        const activeBtn = buttons.find(b => b.innerText === btnText);
        if(activeBtn) activeBtn.classList.add('active');

        // Select only elements with [lang] attribute that are INSIDE the body
        // This prevents selecting the <html lang="en"> tag which caused the white page
        document.querySelectorAll('body [lang]').forEach(el => {
            if (el.getAttribute('lang') === lang) {
                // Restore visibility
                // Check for block-level elements
                if( ['DIV', 'P', 'LI', 'H1', 'H2', 'H3', 'H4', 'UL', 'SECTION'].includes(el.tagName) ) {
                     el.style.display = 'block';
                } 
                // Check for inline-block elements (like tags)
                else if(el.tagName === 'SPAN' && el.classList.contains('tag')) {
                    el.style.display = 'inline-block';
                } 
                // Default to inline for spans, ems, strongs, etc.
                else {
                    el.style.display = 'inline';
                }
            } else {
                el.style.display = 'none';
            }
        });
    }

    // Initialize English
    setLang('en');
</script>

</body>
</html>
